We could not find any results for:
Make sure your spelling is correct or try broadening your search.
InMode Introduces IgniteRF The Complete Minimally Invasive Soft Tissue Contraction Platform PR Newswire IRVINE, Calif., July 31, 2024 IRVINE, Calif., July 31, 2024 /PRNewswire/ -- InMode Ltd...
DOMA Perpetual Sends Letter to the Board of Directors of InMode Urging the Execution of a 40% Tender Offer PR Newswire MIAMI, July 25, 2024 Believes InMode's Cash Balance of Roughly 55% of its...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif., July 17, 2024 IRVINE, Calif., July 17, 2024...
InMode to Report Second Quarter 2024 Financial Results and Hold Conference Call on Aug. 1, 2024 PR Newswire YOKNEAM, Israel, July 11, 2024 Expects Q2 Revenue Between $86.2M-$86.3M, Pro-Forma...
InMode to Present at Jefferies Healthcare Conference PR Newswire YOKNEAM, Israel, May 16, 2024 YOKNEAM, Israel, May 16, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider...
InMode Announces P1 Offshore Racing Partnership with Female Driver Victoria Rand PR Newswire IRVINE, Calif., May 8, 2024 IRVINE, Calif., May 8, 2024 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a...
InMode Reports First Quarter 2024 Financial Results; Quarterly Revenue of $80.3M Represents 24% Year-Over-Year Decrease; Pro Forma Revenue (including new platform pre-orders not yet available) of...
InMode Responds To BTL Petition for Inter Partes Review Of Patent InMode Is Asserting Against BTL PR Newswire YOKNEAM, Israel, April 15, 2024 YOKNEAM, Israel, April 15, 2024 /PRNewswire/...
Shareholders that lost money on InMode Ltd.(INMD) should contact The Gross Law Firm about pending Class Action - INMD PR Newswire NEW YORK, April 12, 2024 NEW YORK, April 12, 2024 /PRNewswire/...
Period † | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions